Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Danuglipron (from Pfizer) showed mixed results and faced development challenges
As a triple-agonist peptide, its generating a level of excitement our team hasn't seen in quite some time
Semaglutide hits one receptor
#MASH #Hepatology #GLP1 #PharmaInsights To view or add a comment, sign in Im excited to share the recent FDA approval of Jascayd (nerandomilast), the first new oral treatment for idiopathic pulmonary fibrosis (IPF) in over a decade
US$ 26.71
US$ 22.42
US$ 22.06
US$ 22.65
US$ 29.06
US$ 20.65
US$ 26.95
US$ 27.76
US$ 28.27
US$ 21.62
US$ 20.78
US$ 27.23
